NCT00051155View on ClinicalTrials.gov

A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2001

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Glaucoma, Open-AngleOcular Hypertension
Interventions
DRUG

Travoprost (0.004%)

DRUG

Latanoprost (0.005%)/Timolol (0.5%)

Trial Locations (1)

Unknown

Europe, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY